Pediatrix Medical Group (Pediatrix Medical Group) EBIT : $-6 Mil (TTM As of Dec. 2023)

View and export this data going back to 1959. Start your Free Trial

What is Pediatrix Medical Group EBIT?

Pediatrix Medical Group's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-129 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Pediatrix Medical Group's annualized ROC % for the quarter that ended in Dec. 2023 was 7.53%. Pediatrix Medical Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -350.96%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Pediatrix Medical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -0.49%.

Pediatrix Medical Group EBIT Historical Data

The historical data trend for Pediatrix Medical Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pediatrix Medical Group EBIT Chart

Pediatrix Medical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

177.71

117.63

203.95

121.07

-6.28

Pediatrix Medical Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial															37.78	31.10	50.18	41.21	-128.77

Competitive Comparison of Pediatrix Medical Group's EBIT

For the Medical Care Facilities subindustry, Pediatrix Medical Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pediatrix Medical Group's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pediatrix Medical Group's EV-to-EBIT falls into.

Pediatrix Medical Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6 Mil.

Pediatrix Medical Group (NYSE:MD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Pediatrix Medical Group's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	156.164 * ( 1 - 10.49% )	/	( (1942.558	+	1772.345)	/ 2 )
=	139.7823964	/	1857.4515
=	7.53 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2326.339	-	313.701	-	( 124.72	-	max(0, 350.444	-	420.524	+	124.72	))
=	1942.558

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2219.81	-	352.957	-	( 177.743	-	max(0, 388.946	-	483.454	+	177.743	))
=	1772.345

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Pediatrix Medical Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-515.076	/	( ( (147.589 + max(-17.897, 0))	+	(145.933 + max(-54.811, 0)) )	/	2 )
=	-515.076	/	( ( 147.589	+	145.933 )	/	2 )
=	-515.076	/	146.761
=	-350.96 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(277.352	+	0	+	18.452)	-	(313.701	+	0	+	0)
=	-17.897

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(272.313	+	0	+	25.833)	-	(352.957	+	0	+	5.6843418860808E-14)
=	-54.811

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Pediatrix Medical Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-6.284	/	1271.736
	=	-0.49 %

Pediatrix Medical Group EBIT Related Terms

Thank you for viewing the detailed overview of Pediatrix Medical Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Pediatrix Medical Group (Pediatrix Medical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

MD:Mexico PDC:Germany

Address

1301 Concord Terrace, Sunrise, FL, USA, 33323

Website

https://www.pediatrix.com

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. The company generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.

Executives

James D Swift	officer: EVP, Chief Operating Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Moore Mary Ann E	officer: EVP Chief ERM/Legal Ops Off	1301 CONCORD TERRACE, SUNRISE FL 33323
Mark S Ordan	director, officer: Chief Executive Officer	7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814
Shirley A Weis	director	11621 RESEARCH CIRCLE, GAINESVILLE FL 32615
Sylvia Jean Young	director	C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054
Lee Wood	officer: EVP, Natl & Market Operations	1301 CONCORD TERRACE, SUNRISE FL 33323
Curtis Pickert	officer: EVP, Chief Operating Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Laura A Linynsky	director	1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Md Medel	director, officer: PRES. & CHIEF EXEC. OFFICER	1301 CONCORD TERRACE, SUNRISE FL 33323
John C Pepia	officer: Principal Accounting Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Mack Hinson	officer: Pres., PDX & OBX Medical Group	C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323
C Marc Richards	officer: EVP, Chief Financial Officer	7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814
Dominic J Andreano	officer: Sr.VP,General Counsel & Secy.	1301 CONCORD TERRACE, SUNRISE FL 33323
Nicholas Nikolopoulos	officer: EVP Chf Strategy & Growth Offi	MEDNAX INC, 1301, SUNRISE FL 33323
Guy P Sansone	director	C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323